Description
MINIRIN (DDAVP) 0.2mg contains Desmopressin, a synthetic analogue of the natural antidiuretic hormone vasopressin, crucial for regulating the body’s water balance. This medication is primarily used to treat central diabetes insipidus, a condition characterized by excessive thirst and urination due to a lack of naturally produced vasopressin. It is also highly effective in managing primary nocturnal enuresis (bedwetting) in children (typically from 5 years of age) and adults when other interventions fail, by significantly reducing nighttime urine production. Furthermore, MINIRIN 0.2mg can provide symptomatic relief for nocturia, helping to reduce the frequency of nighttime urination for improved sleep and quality of life.
